Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.000427 | uM | 7544.092 | 0.9772 | 0.9591 | 1.1147 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.00213 | uM | 7544.092 | 0.9821 | 0.9679 | 1.1147 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.0107 | uM | 7544.092 | 0.9145 | 0.8459 | 1.1147 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.0533 | uM | 7544.092 | 1.0173 | 1.0310 | 1.1147 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.267 | uM | 7544.092 | 1.0154 | 1.0275 | 1.1147 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 1.33 | uM | 7544.092 | 1.0293 | 1.0525 | 1.1147 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 6.67 | uM | 7544.092 | 1.0377 | 1.0676 | 1.1147 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 33.3 | uM | 7544.092 | 0.9559 | 0.9208 | 1.1147 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.0000853 | uM | 7545.092 | 1.0439 | 1.0898 | 0.9794 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.000427 | uM | 7545.092 | 1.0015 | 1.0030 | 0.9794 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.00213 | uM | 7545.092 | 1.0215 | 1.0439 | 0.9794 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.0107 | uM | 7545.092 | 1.0172 | 1.0351 | 0.9794 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.0533 | uM | 7545.092 | 1.0423 | 1.0864 | 0.9794 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.267 | uM | 7545.092 | 1.0025 | 1.0051 | 0.9794 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 1.33 | uM | 7545.092 | 1.0055 | 1.0112 | 0.9794 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 6.67 | uM | 7545.092 | 0.9771 | 0.9533 | 0.9794 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 33.3 | uM | 7545.092 | 0.9613 | 0.9211 | 0.9794 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.000171 | uM | 7546.091 | 1.0326 | 1.0715 | 0.9137 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.000853 | uM | 7546.091 | 1.0146 | 1.0320 | 0.9137 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.00427 | uM | 7546.091 | 1.0127 | 1.0279 | 0.9137 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.0213 | uM | 7546.091 | 1.0241 | 1.0528 | 0.9137 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.107 | uM | 7546.091 | 0.9925 | 0.9837 | 0.9137 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.533 | uM | 7546.091 | 0.9733 | 0.9417 | 0.9137 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 2.67 | uM | 7546.091 | 0.9773 | 0.9504 | 0.9137 | |
| T47DKBLUC | Unknown | Unknown | Erlotinib | EGFR | ErbB | 13.3 | uM | 7546.091 | 0.9068 | 0.7968 | 0.9137 |